| In millions, except per share items | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 8-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues: |
| Research premium and grant revenue | 0.4 | | | | 0.4 | | | |
| Collaboration revenue | 0.1 | | | | 0.6 | | | |
| Product revenue, net | 8.6 | | | | 7.9 | | | |
| Total revenues [+] | 9.2 | 9.2 | 8.0 | 9.3 | 8.9 | 8.2 | 2.5 | 2.5 |
| Products | | | | 8.5 | | | | |
| Revenue growth [+] | 3.3% | 11.5% | 217.1% | 276.5% | 586.4% | 1592.6% | 220.5% | 638.7% |
| Research premium and grant revenue | -16.5% | | | | | | | |
| Collaboration revenue | -74.9% | | | | | | | |
| Product revenue, net | 10.0% | | | | | | | |
| Collaboration revenue - Upfront payment | | | | | | | | -47.3% |
| Cost of goods sold | 4.4 | 4.5 | 3.4 | 5.3 | 4.2 | 3.6 | 0.1 | -0.4 |
| Gross profit | 4.7 | 4.7 | 4.7 | 4.0 | 4.7 | 4.6 | 2.5 | 2.8 |
| Gross margin | 51.8% | 51.5% | 58.1% | 43.1% | 52.6% | 56.1% | 97.5% | 114.8% |
| Selling, general and administrative [+] | 11.9 | 11.0 | 12.7 | 14.5 | 12.3 | 12.9 | 12.0 | 20.2 |
| General and administrative | | | | | | | | 20.2 |
| Research and development | 4.0 | 4.1 | 3.5 | 2.4 | 3.2 | 3.2 | 3.9 | 0.2 |
| Other operating expenses | | | | | | | | 0.7 |
| EBITDA [+] | -11.2 | -10.3 | -11.5 | | -10.7 | -11.3 | -13.3 | -18.2 |
| EBITDA growth | 4.0% | -8.6% | -14.0% | -29.1% | -18.1% | -21.3% | -33.5% | -16.8% |
| EBITDA margin | -122.0% | -112.3% | -143.1% | -139.1% | -121.1% | -137.0% | -527.8% | -738.5% |
| Depreciation and amortization | 0.0 | 0.1 | 0.1 | | 0.1 | 0.1 | 0.1 | 0.1 |
| EBIT [+] | -11.2 | -10.4 | -11.6 | -12.9 | -10.8 | -11.4 | -13.4 | -18.3 |
| EBIT growth | 3.6% | -8.6% | -14.1% | -29.5% | -18.2% | -21.2% | -33.4% | -17.2% |
| EBIT margin | -122.4% | -113.1% | -144.1% | -139.1% | -122.0% | -138.1% | -531.8% | -742.6% |
| Interest expense, net [+] | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Interest expense | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Interest income | | | | | | | | 0.0 |
| Other income (expense), net [+] | 0.4 | -0.1 | 0.3 | 0.0 | 0.1 | 0.5 | -0.1 | 0.6 |
| Other | 0.4 | -0.1 | 0.3 | | 0.1 | 0.5 | -0.1 | 0.6 |
| Pre-tax income | -11.0 | -10.7 | -11.5 | -13.1 | -10.9 | -11.1 | -13.8 | -17.9 |
| Income taxes | 0.5 | 0.4 | 0.4 | -0.1 | -0.3 | 0.6 | 0.2 | -0.1 |
| Tax rate | | | | 0.4% | 2.3% | | | 0.3% |
| Net income | -11.5 | -11.1 | -11.8 | -13.1 | -10.7 | -11.8 | -14.0 | -17.8 |
| Net margin | -125.8% | -120.5% | -147.4% | -141.1% | -120.2% | -142.6% | -552.8% | -724.9% |
| |
| Basic EPS [+] | ($4.21) | ($0.18) | ($0.20) | ($0.24) | ($5.27) | ($0.29) | ($0.53) | ($1.39) |
| Growth | -20.1% | -39.6% | -62.0% | -83.0% | 488.8% | -78.8% | -78.5% | -55.3% |
| Diluted EPS [+] | ($4.21) | ($0.18) | ($0.20) | ($0.24) | ($5.27) | ($0.29) | ($0.53) | ($1.39) |
| Growth | -20.1% | -39.6% | -62.0% | -83.0% | 488.8% | -78.8% | -78.5% | -55.3% |
| |
| Shares outstanding (basic) [+] | 2.7 | 63.2 | 58.8 | 55.5 | 2.0 | 40.6 | 26.4 | 12.8 |
| Growth | 35.2% | 55.9% | 122.6% | 332.0% | -86.0% | 259.8% | 179.2% | 73.1% |
| Shares outstanding (diluted) [+] | 2.7 | 63.2 | 58.8 | 55.5 | 2.0 | 40.6 | 26.4 | 12.8 |
| Growth | 35.2% | 55.9% | 122.6% | 332.0% | -86.0% | 259.8% | 179.2% | 73.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |